viewPembridge Resources PLC

Pembridge Resources CEO says focus moving to new investment opportunities, now operator to be appointed for Minto mine

Pembridge has been instrumental in getting Minto up and running again

Pembridge Resources Plc -

Pembridge Resources Plc (LON:PERE) is to appoint an operator for Minto Explorations Ltd, the company which runs the producing Minto mine in the Yukon.

This will allow Pembridge to focus on complementary activities, including evaluating new investment opportunities.

In line with this desire, the Minto board has passed a resolution to appoint the operator under a contract with Minto Exploration.

"Pembridge has worked hard to get the mine into production since it was acquired in June 2019,” said Gati Al-Jebouri, chief executive of Pembridge in a statement.

He added: “Pembridge has a three-phase development, the first phase being the strengthening of the finances and operations of Pembridge and Minto. It has become apparent that there are a number of inefficiencies associated with the time zone difference between the UK and Yukon

"Therefore, installing an operator for day-to-day support to Minto management not only aims to improve the efficiencies of operating Minto, but reduces the management costs attributable to Pembridge. This step completes phase one of our development strategy and allows Pembridge to concentrate on its next phase of growth.”


Quick facts: Pembridge Resources PLC

Price: 3.25 GBX

Market: LSE
Market Cap: £2.42 m

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events


The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of Pembridge Resources PLC named herein, including the promotion by the Company of Pembridge Resources PLC in any Content on the Site, the Company...



Full interview: Canntab Therapeutics gets first commercial sale with Medipharm

Canntab Therapeutics (CSE: PILL- OTCQB: CTABF) CFO Richard Goldstein and Special Advisor Larry Latowsky joined Steve Darling from Proactive Vancouver with news the company has signed their first contract for their slow release tablets with MediPharm.  Goldstein discusses how the...

9 hours, 38 minutes ago

2 min read